SS Innovations International (NASDAQ:SSII) Director Purchases $1,197,000.00 in Stock

SS Innovations International, Inc. (NASDAQ:SSII) Director Timothy Adams bought 300,000 shares of SS Innovations International stock in a transaction dated Friday, March 6th. The stock was acquired at an average cost of $3.99 per share, with a total value of $1,197,000.00. Following the completion of the acquisition, the director owned 5,331,902 shares of the company’s stock, valued at $21,274,288.98. This represents a 5.96% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

SS Innovations International Trading Up 2.3%

Shares of SSII opened at $4.96 on Friday. The stock has a 50 day moving average of $4.79 and a 200 day moving average of $6.04. The company has a market capitalization of $964.03 million and a price-to-earnings ratio of -82.67. SS Innovations International, Inc. has a 12 month low of $3.02 and a 12 month high of $22.42.

SS Innovations International (NASDAQ:SSII) last posted its quarterly earnings data on Tuesday, March 10th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $14.53 million during the quarter. SS Innovations International had a negative return on equity of 30.23% and a negative net margin of 28.54%.

Hedge Funds Weigh In On SS Innovations International

Several institutional investors and hedge funds have recently bought and sold shares of SSII. PNC Financial Services Group Inc. bought a new stake in shares of SS Innovations International in the third quarter valued at $56,000. Envestnet Asset Management Inc. bought a new position in shares of SS Innovations International during the 3rd quarter worth $71,000. Jane Street Group LLC purchased a new stake in SS Innovations International in the 4th quarter worth about $63,000. IFC & Insurance Marketing Inc. purchased a new stake in SS Innovations International in the 4th quarter worth about $64,000. Finally, Goldman Sachs Group Inc. purchased a new stake in SS Innovations International in the 4th quarter worth about $68,000.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of SS Innovations International in a research report on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, SS Innovations International has a consensus rating of “Sell”.

About SS Innovations International

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.